» Home » Education » PhD Theses 
Print this pageEmail this page URLConvert this page to PDF

Scheduled PhD defences

PhD defences are open to the public, and take place in the J. Schell seminar room of the UGent-VIB research building,  (unless otherwise specified).

Upcoming PhD defences:

Drs. Yehudi Bloch - “Structure, mechanism, and antagonism of the pro-inflammatory receptor complex mediated by interleukin-23”
Monday April 16 at 16:30 - Academieraadzaal, Volderstraat 9, Gent

Drs. Srividhya Sundararaman - “Cadherin repertoires in lower metazoans - Trichoplax adhaerens and Nematostella vectensis
Thursday April 26 at 17:00

IRC Ph.D. theses since 2000

 Pdf-versions of the theses are available on the IRC intranet only (login required ).


  1. Carron Philippe (30-Mar-2018 ; D. Elewaut, F. Van den Bosch)
    New Imaging modalities and treatment strategies in Spondyloarthritis
  2. Delvaeye Tinneke (9-Mar-2018 ; P. Vandenabeele, D. Krysko, L. Leybaert)
    The pathological role of Cx43 and MLKL in TNF-induced Systemic Inflammatory Response Syndrome
  3. Noelanders Rivka (1-Mar-2018 ; K. Vleminckx)
    Wnt/beta-catenin signaling in the Xenopus hindbrain: development and cancer
  4. Tanghe Giel (23-Feb-2018 ; W. Declercq)
    Mechanistic insights into the regulation of RIPK4 and its function in skin homeostasis and pathology
  5. Berings Margot (21-Feb-2018 ; M. Dullaers, P. Gevaert, B. Lambrecht)
    House dust mite allergic rhinitis: A novel take on diagnosis and treatment
  6. Varkas Gaëlle (20-Feb-2018 ; D. Elewaut, F. Van den Bosch)
    Axial spondyloarthritis: New insights in diagnosis and patient stratification
  7. D'hondt Sanne (15-Dec-2017 ; F. Malfait, S. Janssens & M. Bertrand)
    Type III collagen, a major fibrillar collagen with major issues
  8. Dendoncker Karen (13-Oct-2017 ; C. Libert)
    Elucidating the mechanism behind TNF-induced glucocorticoid resistance and strategies to overcome this resistance
  9. Steeland Sophie (5-Oct-2017 ; C. Libert & R. Vandenbroucke)
    Therapeutic targeting of inflammatory mediators in sepsis and neurodegenerative diseases
  10. Favreau Mérédis (4-Oct-2017 ; D. Elewaut, K. Venken, E. Menu & K. Vanderkerken)
    Immune therapy in multiple myeloma: Can iNKT cells be targeted?
  11. Abels Chloé (26-Sep-2017 ; J. Van Ginderachter, P. De Baetselier & A. Beschin)
    Unravelling the role of liver associated myeloid cells in sterile inflammation and infection
  12. De Wilde Katelijne (20-Sep-2017 ; D. Elewaut & S. Lambrecht)
    Novel myeloid regulators of rheumatic diseases
  13. Bogaert Delfien (4-Sep-2017 ; M. Dullaers, F. Haerynck & E. De Baere)
    Molecular diagnosis of Common Variable Immunodeficiency and related antibody disorders: an integrated immunological and genetic approach
  14. Van der Borght Katrien (7-Jul-2017 ; B. Lambrecht)
    Cardiac dendritic cells activate autoreactive T cells in the healthy and diseased heart
  15. Deckers Julie (5-Jul-2017 ; H. Hammad & K. De Bosscher)
    The skin as a central player in house dust mite allergy
  16. Aaes Tania Love (5-Jul-2017 ; P. Vandenabeele & D. Krysko)
    The impact of cell death modalities on the immunogenicity of cancer cells
  17. Vandamme Niels (26-Jun-2017 ; G. Berx)
    ZEB1 and ZEB2 dictate melanocyte homeostasis and melanoma phenotype switching
  18. Ruyssinck Joerie (19-Jun-2017 ; Y. Saeys & T. Dhaene)
    Machine Learning for Biological Network Inference
  19. Krols Michiel (13-Jun-2017 ; S. Janssens & V. Timmerman)
    Mutations in Atlastin-3: implications for ER membrane fusion and crosstalk with mitochondria
  20. Le Cann Fabienne (2-Jun-2017 ; P. Vandenabeele)
    Characterization of new necroptosis innhibitors targeting RIPK1
  21. Udhayakumar Vimal Kumar (24-May-2017 ; J. Grooten & S. De Koker)
    Development and validation of synthetic-virus like vaccines
  22. Van Gassen Sofie (23-May-2017 ; Y. Saeys & T. Dhaene)
    Development of Machine learning techniques for flow cytometry data
  23. Govindarajan Srinath (16-May-2017 ; D. Elewaut & M. Drennan)
    Mechanistic insights into the regulation of iNKT development and cytokine production
  24. Schuijs Martijn (14-Apr-2017 ; H. Hammad and B. Lambrecht)
    The Pathogenesis of House Dust Mite-driven Asthma: From Barn to Bedside
  25. Ladik Maria (4-Apr-2017 ; P. Vandenabeele)
    Development of biosensing systems to monitor necroptosis
  26. Van Nieuwenhuysen Tom (31-Mar-2017 ; K. Vleminckx)
    Modeling human disease in Xenopus tropicalis using programmable nucleases
  27. Urwyler-Rösselet Corinne (17-Mar-2017 ; W. Declercq & P. Vandenabeele)
    Study of the functions of RIPK4 in epidermal development and signal transduction
  28. Balusu Sriram (15-Mar-2017 ; R. Vandenbroucke & C. Libert & K. Gevaert)
    Novel insights into the choroid plexus response to systemic inflammation and Alzheimer's disease
  29. Vermeulen Ilke (3-Mar-2017 ; J. Grooten)
    Tuberculosis: how different synthetic analogues of pathogen associated mycolates affect lipid homeostasis of murine host macrophages
  30. Catrysse Leen (24-Feb-2017 ; G. van Loo & R. Beyaert)
    Diabetes and inflammation, how A20 regulates tissue homeostasis in metabolic tissues
  31. Sichien Dorine (24-Feb-2017 ; B. Lambrecht & M. Guilliams)
    Differential requirement for IRF8 in the development and function of monocytes and dendritic cells
  32. Tavernier Simon (31-Jan-2017 ; B. Lambrecht & S. Janssens)
    Dendritic cells under stress: on the role of the unfolded protein response and hypoxia signalling
  33. Cypers Heleen (23-Jan-2017 ; D. Elewaut)
    The role of intestinal inflammation in initiation, monitoring and outcome of spondyloarthritis
  34. De Beuckelaer Ans (23-Dec-2016 ;J. Grooten)
    mRNA-based vaccines to elicit CD8 T cell immunity
  35. Borghi Alice (22-Dec-2016 ;R. Beyaert)
    New insight into the ubiquitin-mediated regulation of TNFR2 signaling
  36. Hassannia Behrouz (22-Dec-2016 ;P. Vandenabeele)
    Ferroptosis: triggers, inhibitors and therapeutic potential in neuroblastoma
  37. Van Putte Wouter (19-Dec-2016 ;S. Savvides)
    The type II secretion system and membrane vesiculation: bacterial secretion systems as a target for anti-virulence drug development
  38. Meloni Laura (8-Dec-2016 ;R. Beyaert)
    Molecular mechanisms of mechanotransdcution and osteoclastogenesis in arthritis
  39. Gül Ismail Sahin (6-Dec-2016 ;F. Van Roy)
    Molecular evolution of the armadillo repeat superfamily and characterization of representative members in key model organisms
  40. Demeestere Delphine (2-Dec-2016 ;C. Libert & R. Vandenbroucke)
    A study of inflammatory mechanisms involved in systemic inflammation and brain trauma
  41. Ballegeer Marlies (2-Dec-2016 ;C. Libert & R. Vandenbroucke)
    Study of the role and regulation of Glucocorticoid induced leucine zipper (GILZ) and GR dimers in acute inflammation
  42. Neyt Katrijn (21-Oct-2016 ;B. Lambrecht & M. Guilliams)
    Pulmonary immune responses against influenza A virus infection
  43. Jimenez Fernandez Daniel (22-Sep-2016 ;L. Lamkanfi & K. Gevaert)
    Functional characterization of inflammatory caspases
  44. Billi Eleonora (22-Sep-2016 ; F. Van Roy & J. Tavernier)
    Identification and functional analysis of molecular interaction partners of δ-protocadherin family members with putative roles in cancer
  45. Sips Magdalena (31-Aug-2016 ; P. Brouckaert)
    Harnessing innate immunity to prevent and control HIV infection
  46. Demeyer Annelies (28-Jun-2016 ; R. Beyaert)
    Functional characterization of the paracaspase MALT1 in T cells
  47. Grootjans Sasker (15-Apr-2016 ; P. Vandenabeele)
    Identification of potential RIPK1 substrates during Necroptosis
  48. Aguileta Miguel (15-Apr-2016 ; M. Bertrand & P. Vandenabeele)
    Characterization of new proteins involved in apoptosis regulation
  49. Juchtmans Nele (22-Mar-2016 ; D. Elewaut)
    The role of stress related proteins in osteoarthritis
  50. Félix Jan (7-Jan-2016 ; S. Savvides)
    Structural Principles of binding duality in cognate and viral cytokine receptors
  51. Petta Ioanna (4-Dec-2015 ; C. Libert & J. Tavernier)
    Identification of striatin-3 and ZBTB32 as two novel modulators of glucocorticoid receptor activity
  52. Sipieter François (3-Dec-2015 ; F. Riquet, P. Vandenabeele, K. Cailliau-Maggio & L. Héliot)
    Development and validation of kinase activity reporters for the dynamical study of cell response modalities by microscopy ~ Role of the kinase MAPK/ERK in necroptosis.
  53. Deng Lei (3-Dec-2015 ; X. Saelens)
    Targeted prokaryotic delivery of a conserved influenza A virus epitope for oral vaccination
  54. Santens Francis (25-Sep-2015 ; N. Callewaert)
    Engineering of protein production systems to drastically reduce glycan heterogeneity of biopharmaceuticals
  55. Claes Katrien (11-Sep-2015 ; N. Callewaert)
    Development of modular engineering tools for membrane protein expression in yeast
  56. Dondelinger Yves (3-Jul-2015 ; P. Vandenabeele & M. Bertrand)
    Unraveling the molecular mechanisms of RIPK1-mediated cell death
  57. Vandewalle Kristof (19-Jun-2015 ; N. Callewaert)
    Building genome-wide mutant resources in slow-growing mycobacteria
  58. De Visscher Charlotte (20-Feb-2015 ; N. Callewaert)
    Engineering of the production of mannose-6-phosphate-modified lysosomal enzymes by the yeast Pichia pastoris
  59. Elton Lynn (19-Dec-2014 ; R. Beyaert)
    Identification and functional characterization of novel MALT1 substrates
  60. Smet Muriel (18-Dec-2014 ; J. Grooten)
    Cholesterol-sensing liver X receptors and mycolic acid bio-lipids at the crossroads of lipid metabolism and inflammation
  61. Mueller Christina (16-Dec-2014 ; R. Beyaert)
    Molecular and functional characterization of interleukin-33 signaling
  62. Volckaert Thomas (8-Dec-2014 ; R. Beyaert)
    Epithelial-mesenchymal crosstalk during lung development and regeneration
  63. Grine Lynda(25-Nov-2014 ; C. Libert)
    Study of the role of type I Interferons in TNF-mediated inflammation.
  64. Tyberghein Koen (30-Sep-2014 ; F. Van Roy)
    Alpha-catenins: protein replacement as a strategy against cancer invasion and metastasis?
  65. Ydens Elke (24-Apr-2014 ; S. Janssens & V. Timmerman)
    Activation of the innate immune response during peripheral nerve degeneration: from pattern recognition receptors to immune effector cells
  66. Broos Stefan (24-Jan-2014 ; F. Van Roy & P. De Bleser)
    Developing algorithms for the in silico identification of transcription factor binding sites
  67. Vandendriessche Benjamin (13-dec-2013 ; P. Brouckaert & A. Cauwels)
    Complex dynamics in systemic inflammation: quantification of coupling and targeting of the nitric oxide-soluble guanylate cyclase axis
  68. Pollard Charlotte (6-dec-2013 ; J. Grooten & S. De Koker)
    Evaluation of CD8+ T cell responses upon mRNA vaccination and the implication of type I IFN signaling
  69. Puimège Leen (29-nov-2013 ; C. Libert)
    A molecular genetic analysis of TNFR1 regulation in SPRET/EI and generation of new TNFR1 inhibitory tools
  70. Vandevyver Sofie (22-nov-2013 ; C. Libert)
    Study of the molecular mechanisms of glucocorticoid receptor function and resistance in TNF-induced toxicity
  71. Plantinga Maud (16-Oct-2013 ; Bart Lambrecht)
    The role of dendritic cell subsets in allergic sensitization
  72. Ayiseh Rene B. (19-Sep-2013 ; P. Vandenabeele)
    Role of cell death and caspases in intestinal inflammation
  73. Kaczmarek Agnieszka (4-Jul-2013 ; P. Vandenabeele)
    Sensing of apoptotic and necroptotic cell death by the innate immune system
  74. Willart Monique (27-Jun-2013 ; B. Lambrecht)
    Immune activation at the lung epithelial barrier
  75. McGuire Conor (31-May-2013 ; G. van Loo & R. Beyaert)
    The study of signaling pathways controlling central nervous system inflammation and pathology
  76. De Baets Sarah (10-Apr-2013 ; X. Saelens)
    Novel vaccination strategies against human repiratory syncytial virus
  77. Pringels Sarah (17-Apr-2013 ; J. Grooten)
    Screening of the Vascular Endothelial Growth Factor family in human colon cancer
  78. Cardoso Francisco Miguel Lopez (28-Feb-2013 ; X. Saelens)
    Antiviral activity of camelid single domain antibodies targeting the neuraminidase of H5N1 Influenza virus
  79. De Groote Philippe (21-dec-2012 ; W. Declercq)
    Study of RIPK4 function in skin homeostatsis and disease
  80. Devos Michael (21-dec-2012 ; W. Declercq)
    Study on the role of delatNp63alpha and caspase-14 in skin homeostasis and pathology
  81. Kahr Irene (20-dec-2012 ; F. Van Roy)
    Functional analysis of the candidate tumor suppressor protein protocadherin-10
  82. Verhelst Judith (19-dec-2012 ; X. Saelens)
    Unraveling the antiviral mechanism of mouse Mx1 directed against influenza A
  83. Janssens Sylvie (19-Oct-2012 ; K. Vleminckx)
    Identification of novel target genes of the Wnt/β-catenin pathway during Xenopus development and analysis of their epigenetic regulation
  84. Haenebalcke Lieven (5-Oct-2012 ; J. Haigh)
    Generation and use of novel ROSA26-based ESC/iPSC technologies to study cellular reprogramming and gene function during lineage-directed differentiation
  85. Naessens Thomas (6-Jul-2012 ; J. Grooten)
    Functional dynamics of resident alveolar macrophages in a mouse model of allergic asthma
  86. Vander Beken Seppe (6-Jul-2012 ; J. Grooten)
    Mycobacterium tuberculosis bio-lipid mycolic acid and mammalian cholesterol-sensor liver X-receptor in airway immunity
  87. Farhang Ghahremani Morvarid (5-Jul-2012 ; J. Haigh)
    Molecular and genetic interplay between p53 and VEGF in tumour angiogenesis
  88. Meuris Leander (2-Jul-2012 ; N. Callewaert)
    GlycoDelete: a new glycoengineering concept for protein production in mammalian cells
  89. Nittner David (8-Jun-2012 ; J.C. Marine)
    Role of the microRNA pathway in retinoblastoma
  90. Guerfal Mouna (8-May-2012 ; N. Callewaert)
    Yeast secretory system engineering for enhanced membrane protein expression
  91. Roose Kenny (26-Jan-2012 ; X. Saelens)
    Design and validation of novel broad influenza B vaccine
  92. Andries Vanessa (26-Jan-2012 ; F. Van Roy)
    Functional analysis of the NBPF1 gene in cancer
  93. Bekaert Tine (20-Jan-2012 ; R. Beyaert)
    Functional characterization of the paracaspase MALT1
  94. Gembarska Agnieszka (19-Jan-2012 ; J.C. Marine)
    MDMX is a key therapeutic target in skin melanoma
  95. Schotsaert Michael (16-Dec-2011 ; X. Saelens)
    Modulation of humoral and cellular immunity to influenza by vaccination
  96. Zwolinska Aleksandra (15-Dec-2011 ; J.C. Marine)
    Study of three putative nuclear modulators of the p53 pathway
  97. Fransen Mathias (9-Dec-2011 ; K. Vleminckx)
    Exploring the role of caspases and RIPK4 during Xenopus development
  98. Van Hauwermeiren Filip (25-Nov-2011 ; C. Libert)
    New strategies to prevent TNF-induced toxicity in TNF/IFNgamma-based anti-tumor models
  99. Gheldof Alexander (21-Oct-2011 ; G. Berx)
    Functional analysis of the EMT inducing transcription factor ZEB1 during malignant carcinoma progression
  100. Duprez Linde (14-Oct-2011 ; P. Vandenabeele)
    Role of RIP1 in TNF-induced cell death in vitro and in vivo
  101. Tatari Marianthi (26-Sep-2011 ; G. Berx)
    In vivo analysis of the role of ZEB2 in epithelial homeostasis and tumor progression
  102. Pinheiro Iris (8-Jul-2011; C. Libert)
    Molecular cloning of the X-chromosome located LPS-resistance gene of SPRET/Ei mice
  103. Maelfait Jonathan (8-Jul-2011; R. Beyaert)
    Signaling in antiviral immunity and its regulation by the ubiquitin-editing protein A20
  104. Lambertz Irina (6-Jul-2011; J.C. Marine)
    MicroRNA control of cancer development
  105. Vanlangenakker Nele (1-Jul-2011; P. Vandenabeele)
    Unraveling TNF-induced necrotic signaling pathways using RNA interference and live-cell imaging
  106. Quimbaya Mauricio (23-Jun-2011; L. De Veylder & G. Berx)
    Identification of novel conserved cell cycle genes through data integration and comparative genomics between plants and humans
  107. Verhelst Kelly (17-Jun-2011; R. Beyaert)
    Molecular analysis of the ubiquitin-editing protein A20
  108. Vereecke Lars (27-May-2011; R. Beyaert)
    Controlling inflammation and cell death at the intestinal epithelial interface and beyond: Lessons from conditional 120 knockout mice
  109. De Pourcq Karen (27-May-2011; N. Callewaert)
    Glycosylation engineering in the yeast Yarrowia lipolytica: creating an expression system to produce complete homogeneous glycoproteins
  110. Wirawan Ellen (8-Apr-2011; P. Vandenabeele)
    Molecular interplay between autophagy and apoptosis through caspase-mediated cleavage of Beclin-1
  111. Kersse Kristof (8-Apr-2011; P. Vandenabeele)
    Inflammasome modulation and NF-kB activation by caspase-1-related CARD domains
  112. Dejonckheere Eline (1-Apr-2011; C. Libert)
    The role of matrix metalloproteinase 8 in TLR4-mediated acute systemic inflammation
  113. Pieters Tim (25-Feb-2011; F. Van Roy)
    Functional analysis of mice harboring a knock-out or knock-in of the alternatively spliced exon C of p120ctn
  114. Hooghe Bart (25-Feb-2011; F. Van Roy)
    In silico approaches to studying transcriptional gene regulation: prediction of transcription factor binding sites and applications thereof
  115. De Clercq Sarah (5-Jul-2010; J.-C. Marine)
    Study of the physiological and oncogenic properties of Mdm2 and Mdm4
  116. Van Bogaert Tom (1-Jul-2010; C. Libert)
    Study of the molecular mechanism of glucucorticoid resistance in tumor necrosis factor-induced systemic inflammation
  117. Galle Marlies (1-Jul-2010; R. Beyaert)
    Modulation of macrophage immune responses by the Pseudomonas aeruginosa type three secretion system
  118. Hoste Esther (24-Jun-2010; W. Declercq & P. Vandenabeele)
    Study of the role of caspase-14 in epidermal cornification
  119. Lefever Tine (3-Jun-2010; F. Van Roy)
    Analysis of N-WASP function in keratinocytes in vivo
  120. Vanderschaeghe Dieter (1-Jun-2010; J. De Langhe & N. Callewaert)
    GlycoHepatoTest: validation and analytical technology development for implementation on microfluidics analyzer
  121. Dejager Lien (30-Apr-2010; C. Libert)
    Molecular and genetic analysis of the resistance of the mouse strain SPRET/Ei to endotoxemia and Gram-negative sepsis
  122. Houthuys Erica (2-Apr-2010; P. Brouckaert)
    Transcriptome analysis of monocytes and macrophages in mycobacterial infection and chronic kidney disease
  123. Thoonen Robrecht (26-Feb-2010; P. Brouckaert)
    Generation and characterization of apo-soluble Guanylate Cyclase mice
  124. Vanhooren Valerie (27-Nov-2009; C. Libert)
    Glycomics of mammalian aging
  125. Crabbe Ellen (20-Nov-2009; K. Vleminckx)
    Identification and functional characterization of novel N-cadherin interacting proteins
  126. Willemarck Nicolas (20-Nov-2009; K. Vleminckx)
    Het Xenopus embryo als experimenteel platform voor de exploratie van nieuwe functies voor caspasen en tumorgeassocieerde de novo lipogenese
  127. Schoonooghe Steve (19-Oct-2009; J. Grooten)
    Multivalent and cross-reactive bispecific bibodies and tribodies for enhanced MUC1 tumour targeting
  128. Vanlaere Ineke (24-Sep-2009; C. Libert)
    Role of MMP-7 and IL-17A in acute systemic inflammation
  129. Demon Dieter (22-Jun-2009; P. Vandenabeele)
    Caspase-7: protease specificity activation and construction of a conditional knockout
  130. Tran Hong Thi (19-Jun-2009; K. Vleminckx)
    Development and use of novel transgenic lines to study Wnt signaling in the Xenopus embryo
  131. Huang Lieven (7-Jan-2009; R. Beyaert/P. De Baetselier)
    Characterization of EGF receptor targeting Nanobodies and ABIN for the treatment of EGF receptor-dependent tumours
  132. De Koker Stefaan (28-Oct-2008; N. Mertens/J. Grooten)
    Polyelectrolyte microcapsules for antibody delivery
  133. Huyghe Leander (10-Oct-2008; P. Brouckaert)
    Study of molecular and immunological factors that determine the sensitivity to the antitumor effect of Tumor Necrosis factor
  134. Bogaert Pieter (27-Mar-2008; J. Grooten)
    Transcriptome profiling of macrophage activation and inflammatory mediator expression in experimental mouse models of allergic pulmonary inflammation
  135. Jacobs Pieter (29-Feb-2008; N. Callewaert)
    Glycosylation and cell surface engineering in Pichia pastoris
  136. Vandewalle Cindy (28-Feb-2008; G.Berx & F. Van Roy)
    The role and mechanisms of SIP1 in the dedifferentiation of epithelial cancers
  137. Beekman Chantal - (21-Jan-2008; J.-C. Marine & F. Van Roy)
    A study of three putative players in the p53 pathway: Nucleostemin, Ptprv and TCTP
  138. Verschuere Veerle - (20-Dec-2007; K. Vleminckx)
    Analysis of the role of the p120 catenin subfamily in cell adhesion and cell migration during the early development of Xenopus laevis
  139. Loos Michaela - (7-Dec-2007; E. Remaut)
    Modulation of dendritic cell function through delivery of effector proteins by genetically modified Lactococcus lactis
  140. Coornaert Beatrice - (30-Nov-2007; R. Beyaert)
    MALT1 paracaspase-mediated regulation of the NF-kappaB inhibitory protein A20 in antigen receptor signaling
  141. Van Huynegem Karolien - (23-Nov-2007; E. Remaut)
    Genetically modified Lactococcus lactis as a tool in the prevention and healing of chemotherapy-induced intestinal mucositis
  142. Ovaere Petra - (5-Oct-2007; P. Vandenabeele)
    Identification of a Caspase-14 activating protease in murine skin extracts
  143. Verstrepen Lynn - (5-Oct-2007; R. Beyaert)
    Functional characterization of ABIN-3 and TAX1BP1 as negative regulators of NF-kappaB signaling
  144. Vande Walle Lieselotte - (28-Sep-2007; P. Vandenabeele)
    Role of the mitohondrial serine protease HtrA2/Omi in apoptosis
  145. Sips Patrick  (6-Jul-2007; P. Brouckaert)
    Functional analysis of soluble guanylate cyclase isoforms using mouse transgenics: cardiovascular effects of targeted mutagenesis of the alpha 1 subunit
  146. Vercammen Elisabeth  (22-Jun-2007; R. Beyaert)
    The secret life of Interleukin-1beta: molecular mechanisms involved in its production and biological activities
  147. Goethals An  (11-May-2007; P. Brouckaert)
    Studie in muismodellen van de mechanismen verantwoordelijk voor het antitumoraal effect van Tumor Necrosis Factor
  148. Van Lint Philippe  (20-apr-07, 16h30; C. Libert)
    The role of matrix metalloproteinases in specific inflammatory disorders
  149. Van Roy Maarten  (20-apr-07, 14h00;  C. Libert)
    New strategies to improve the safety and efficacy of a TNF/IFNgamma-based antitumor therapy
  150. Schepens Bert  (6-Oct-2006; R. Beyaert)
    The great escape: how Internal Ribosome Entry Sites can initiate translation of crucial mRNAs during hypoxia and mitosis
  151. De Smet Kris  (29-Sep-2006; R. Contreras)
    Studie van het celdoodproces in Candida albicans
  152. Schauvliege Reinout  (29-Sep-2006; R. Beyaert)
    Molecular mechanisms of LPS-induced pro-inflammatory signalling
  153. Delvaye Mieke  (28-Sep-2006; F. Van Roy & K. Vleminckx)
    Analysis of the morphogenetic role of known and novel cadherin-interacting proteins in Xenopus laevis
  154. Festjens Nele  (7-Jul-2006; P. Vandenabeele & X. Saelens)
    Characterization of molecular mechanisms associated with and involved in necrotic cell death
  155. Krysko Dmitri  (5-Jul-2006; K. D'Herde & P. Vandenabeele)
    Cell death: Initiation, propagation and clearance
  156. Laukens Debby  (29-Jun-2006; E. Remaut & P. Rottiers)
    Transcriptome profiling and genetic analysis to identify and characterize susceptibility genes for Crohn's disease
  157. Wullaert Andy  (5-May-2006; R. Beyaert)
    Effect of ABINs on intracellular signaling pathways involved in TNF-mediated liver injury
  158. Mahieu Tina  (31-Mrch-2006; C. Libert)
    A molecular analysis of the LPS resistance of the mouse species /Mus spretus
  159. Bultinck Jennyfer  (16-Mrch-06; P. Brouckaert)
    (Sub)cellular expression patterns and pathophysiological significance of INOS in inflammatory shock
  160. Goossens Steven  (24-Feb-06; F. Van Roy)
    Functional analysis of mouse alpha T-catenin
  161. Heirman Ingeborg  (1-Feb-06; J. Grooten)
    The tumor cell oxidative status and its interaction with eicosanoid synthesis in the control of tumor growth and malignant progression
  162. Vandepoele Karl  (22-Dec-2005; F. Van Roy)
    Genomic characterization and functional analysis of the novel NBPF gene family
  163. Termont Sofie  (16-Dec-2005; E. Remaut & P. Rottiers) 
    Optimization of Lactococcus lactis mediated mucosal delivery of cytokines
  164. Ryckaert Stefan  (9-Dec-2005; R. Contreras)
    Ontwikkeling van nieuwe toepassingen voor gist oppervlakte-expressie
  165. Soubry Adelheid  (6-Dec-2005; F. Van Roy)
    Analyse van de transcriptionele repressor Kaiso in humane tumoren en tijdens de celcyclus
  166. Denayer Tinneke  (2-Dec-05; F. Van Roy & K. Vleminckx)
    Functional study of the canonical Wnt pathway using transgenic tools in Xenopus laevis
  167. De Craene Bram  (19-may-05; F. Van Roy & G. Berx)
    The role of the Snail family of transcription factors in epithelial-mesenchymal transitions
  168. Van Belle Tom  (25-mar-05; J. Grooten)
    IL-15, a cytokine with direct action on CD8+ T cells, exerts an indirect action on TCR-stimulated CD4+ T cells
  169. Vanden Berghe Tom  (18-feb-05; P. Vandenabeele)
    Molecular interplay between apoptotic and necrotic cell death pathways
  170. Willems An   (28-jan-05; N. Mertens & J. Grooten)
    Tumorafhankelijke T cel activering met bispecifieke antilichamen: optimalisatie door protein-design
  171. Brouckaert Greet  (27-jan-05; P. Vandenabeele)
    Analysis of a cellular model for the recognition and phagocytosis of apoptotic and necrotic cells by macrophages
  172. Lamkanfi Mohamed  (10-nov-04; P. Vandenabeele)
    CARD proteins in apoptosis and inflammation
  173. Reekmans Rieka  (23-sep-04; R. Contreras)
    Transcriptional profiling of the Bax-responsive genes in S. cerevisiae.
  174. Vandenbroucke Klaas  (10-sep-04; E. Remaut, L. Steidler & P. Rottiers)
    Genetically modified Lactococcus lactis as in vivo delivery system for trefoil factors at the intestinal mucosa.
  175. Geysens Steven  (28-jun-04; R. Contreras)
    Klonering en karakterisering van fungale genen betrokken bij eiwit N-glycosylatie, kwaliteitscontrole en secretie.
  176. Vervecken Wouter  (28-jun-04; R. Contreras)
    Modificatie van de N-glycosylatiesyntheseweg van Aspergillus niger en Pichia pastoris.
  177. van Gurp Marjan (25-jun-04; P. Vandenabeele)
    Identification of protein-protein interactions in cell death signalling using the yeast two-hybrid system
  178. Staelens Jan  (31-mrt-04; C Libert)
    A molecular genetic analysis of the TNF resistance of the mouse species Mus spretus
  179. Bogaerts Sven  (13-feb-04; F. Van Roy)
    Characterization of a novel zinc finger protein ANC_2H01 (ZASC1)
  180. Pynaert Gwenda  (21-nov-03; J. Grooten)
    De regulerende werking van macrofagen op luchtweginflammatie in een muismodel voor astma 
  181. Vanpoucke Griet  (26-sep-03; F. Van Roy & G. Berx)
    The human alpha-catenins : regulation mechanisms controlling their expression
  182. Comijn Joke  (26-sep-03; F. Van Roy & G. Berx)
    SIP1-mediated transcriptional regulation of E-cadherin and identification of new SIP1 target genes
  183. Lippens Saskia  (12-sep-03; P. Vandenabeele & W. Declercq)
    Expression, regulation and processing of caspase-14 during epidermal differentiation
  184. Vanhalst Koen  (29-aug-03; F. Van Roy)
    Identification and functional analysis of new cadherin genes, possibly involved in murine brain development
  185. Buys Emmanuel  (23-may-03; P. Brouckaert)
    Target validation od soluble guanylate cyclase using conditional targeted mutagenesis in mice
  186. Carpentier Isabelle  (9-may-03; R. Beyaert)
    Molecular and functional characterization of the tumor necrosis factor receptor associated proteins TRAF1 and TRAF2
  187. Hostens Jeroen  (24-apr-03; P. Brouckaert)
    Onderzoek naar het mechanisme van de versterkende werking van IFN-gamma op het anti-tumoraal effect van TNF
  188. Janssens Sophie  (21-febr-03; R. Beyaert)
    Regulation of Interleukin-1 and endotoxin-induced responses by alternative splicing of MyD88
  189. Van Oekelen Dirk  (28-juni-02; G. Haegeman)
    The 5-HT2 receptor family: atypical regulation and functional insight through altered gene expression using antisense
  190. van Loo Geert  (14-juni-02; P. Vandenabeele)
    Apoptotic and necrotic cell death: cell death domain proteins and release of mitochondrial factors
  191. Strumane Kristin  (14-juni-02; F. Van Roy)
    E-cadherin-dependent differential gene expression in cancer cells reveals the novel E-cadherin-repressed oncogene hECRep1
  192. Callewaert Nico  (31-mei-02; R. Contreras) 
    Protein N-glycosylation : from yeast to man
  193. Vermeulen Linda  (17-mei-02; G. Haegeman)
    Studie van het moleculair mechanisme voor transcriptionele activering van NF- B p65 na inflammatorische stimulatie
  194. Bonné Stefan  (30-apr-02; F. Van Roy)
    Klonering en functionele karakterisering van het desmosomale eiwit plakophiline-3
  195. Janssens Barbara  (29-mrt-02; F. Van Roy)
    Study of two novel members of the human alpha-catenin family
  196. Wielockx Ben  (29-mrt-02; C. Libert & P. Brouckaert)
    De rol van proteasen en de identificatie van genen, coderend voor beschermende eiwitten, in TNF-geïnduceerde hepatitis en letale shock
  197. Hochepied Tino  (21-sep-01; P.Brouckaert & C.Libert)
    Onderzoek naar de rol van acute-fase proteïnen, in het bijzonder alfa1-zuur glycoproteïne, in muismodellen voor lokale en systemische inflammatie
  198. Van Huffel Sofie  (21-sep-01; F. Van Roy & R.Beyaert)
    Identificatie en functionele karakterisering van eiwitten die binden met het zinkvingereiwit A20
  199. Vanhauwe Jurgen  (15-jun-01; G. Haegeman & J. Leysen)
    Karakterisering van de ligand-bindings- en signaaltransductie-eigenschappen van humane dopamine D2- en D3-receptoren
  200. Francken Bart  (17-apr-01; G. Haegeman)
    Heterologous expression of G protein-coupled receptors and reconstituion of G protein coupling : h5-ht5A receptor in mammalian, insect, and bacterial cells
  201. De Wilde Gert  (10-jan-01; G. Haegeman)
    Studie van de ruimtelijke structuur van het TNFR-55 'death domain' en van de stroomafwaartse signalisatie naar MAP-kinasen
  202. Schotte Peter  (15-dec-00; R. Beyaert &F. Van Roy)
    Studie van caspasen en het activeringsmechanismen
  203. Van Craenenbroeck Kathleen  (21-jun-00; G. Haegeman)
    Onderzoek van induceerbare systemen voor heterologene genexpressie in zoogdiercellen
  204. Vanlandschoot Ann  (10-mei-00; F. Van Roy)
    Isolering en karakterisering van catenine- en cadherine-bindende eiwitten met mogelijke functies in signalisatiewegen en genregulatie
  205. Laroy Wouter  (9-mei-00; R. Contreras)
    Structuur-functie analyse van siaalzuur transfererende enzymen
  206. De Bosscher Karolien  (23-mrt-00; G. Haegeman)
    Onderzoek naar het mechanisme van Genrepressie door Glucocorticoïden
  207. Denecker Geertrui  (17-mrt-00; W. Fiers & P. Vandenabeele)
    Role of capases and mitochondria in apoptotic and necrontic cell death
  208. De Backer Marianne  (11-feb-00; R. Contreras)
    Identification of novel molecular targets for drugs against Candida albicans
  209. Dooms Hans  (28-jan-00; J. Grooten &F. Van Roy)
    Differentiële regulatie van apoptose en celdeling door interleukine-2 en -15 tijdens T-lymfocyt-antwoorden